Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.1 passage
• A 20-year-old man with back pain and lower extremity weakness.1 passage
• A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia.1 passage
• A 5-Decade Analysis of Incidence Trends of Ischemic Stroke After Transient Ischemic Attack: A Systematic Review and Meta-analysis.1 passage
• A 63-Year-Old Man With Progressive Visual Symptoms.1 passage
• A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.1 passage
• A Man in His 40s With Headache, Lethargy, and Altered Mental Status.1 passage
• A Middle-aged Man With Progressive Ophthalmoparesis, Ataxia, and Spastic Paraparesis.1 passage
• A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia: A Broadened Spectrum of SCA34.1 passage
• A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage.1 passage
• A Rare Cause of Myoclonus: A Cupric Conundrum.1 passage
• A Review of the Current Therapies, Challenges, and Future Directions of Transcranial Focused Ultrasound Technology: Advances in Diagnosis and Treatment.1 passage
• A Thalamocortical Mechanism for the Absence of Overt Motor Behavior in Covertly Aware Patients.1 passage
• A Woman in Her 40s With Headache and New-Onset Seizures.1 passage
• A Woman in Her 60s With Chronic Meningitis.1 passage
• A Young Man With Progressive Language Difficulty and Early-Onset Dementia.1 passage
• A Young Man With Progressive Vision and Hearing Loss.1 passage
• A Young Woman With Blurred Vision and Distal Paresthesias.1 passage
• A genome-wide association study of myasthenia gravis.1 passage
• A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.1 passage
• A rare cause of radiculomyelitis: dural arteriovenous fistula.1 passage
• ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.1 passage
• Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis.1 passage
• Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.1 passage
• Acute Brain Lesions on Magnetic Resonance Imaging and Delayed Neurological Sequelae in Carbon Monoxide Poisoning.1 passage
• Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial.1 passage
• Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.1 passage
• Adolescent-Onset and Adult-Onset Vitamin-Responsive Neurogenetic Diseases: A Review.1 passage
• Advances in Sequencing Technologies for Understanding Hereditary Ataxias: A Review.1 passage
• Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review.1 passage
• Advantages and limitations of teleneurology.1 passage
• Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.1 passage
• Agent Orange Exposure and Dementia Diagnosis in US Veterans of the Vietnam Era.1 passage
• Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials.1 passage
• Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.1 passage
• Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial.1 passage
• Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.1 passage
• Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease.1 passage
• An 8-Year Follow-up on the Effect of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease.1 passage
• Analysis of Morbidity and Outcomes Associated With Use of Subdural Grids vs Stereoelectroencephalography in Patients With Intractable Epilepsy.1 passage
• Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.1 passage
• Analysis of Normal High-Frequency Intracranial Pressure Values and Treatment Threshold in Neurocritical Care Patients: Insights into Normal Values and a Potential Treatment Threshold.1 passage
• Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis.1 passage
• Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype.1 passage
• Anatomical Wiring and Functional Networking Changes in the Visual System Following Optic Neuritis.1 passage
• Angiotensin-converting enzyme inhibitors and amyotrophic lateral sclerosis risk: a total population-based case-control study.1 passage
• Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms.1 passage
• Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.1 passage
• Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis.1 passage
• Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy.1 passage
• Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.1 passage
• Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy.1 passage
• Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results.1 passage
• Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.1 passage
• Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome.1 passage
• Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.1 passage
• Assessing Spinal Cerebrospinal Fluid Leaks in Spontaneous Intracranial Hypotension With a Scoring System Based on Brain Magnetic Resonance Imaging Findings.1 passage
• Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.1 passage
• Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.1 passage
• Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial.1 passage
• Assessment of Brain Injury Using Portable, Low-Field Magnetic Resonance Imaging at the Bedside of Critically Ill Patients.1 passage
• Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.1 passage
• Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members.1 passage
• Assessment of Eating Behavior Disturbance and Associated Neural Networks in Frontotemporal Dementia.1 passage
• Assessment of Emergency Department and Inpatient Use and Costs in Adult and Pediatric Functional Neurological Disorders.1 passage
• Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry.1 passage
• Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.1 passage
• Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016.1 passage
• Assessment of Optimal Patient Selection for Endovascular Thrombectomy Beyond 6 Hours After Symptom Onset: A Pooled Analysis of the AURORA Database.1 passage
• Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes.1 passage
• Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.1 passage
• Assessment of Racial/Ethnic Disparities in Timeliness and Comprehensiveness of Dementia Diagnosis in California.1 passage
• Assessment of Recurrent Stroke Risk in Patients With a Carotid Web.1 passage
• Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.1 passage
• Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial.1 passage
• Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders.1 passage
• Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study.1 passage
• Assessment of the Predictive Validity of Etiologic Stroke Classification.1 passage
• Assessment of the Predictive Value of Outpatient Smartphone Videos for Diagnosis of Epileptic Seizures.1 passage
• Assessment of the Utility of Ictal Magnetoencephalography in the Localization of the Epileptic Seizure Onset Zone.1 passage
• Assessment of the Validity of the 2HELPS2B Score for Inpatient Seizure Risk Prediction.1 passage
• Associated Factors and Prognostic Implications of Stimulus-Induced Rhythmic, Periodic, or Ictal Discharges.1 passage
• Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.1 passage
• Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment.1 passage
• Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.1 passage
• Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.1 passage
• Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.1 passage
• Association Between Atrial Fibrillation and Dementia in the General Population.1 passage
• Association Between Birth in a High Stroke Mortality State, Race, and Risk of Dementia.1 passage
• Association Between Blood Pressure and Later-Life Cognition Among Black and White Individuals.1 passage
• Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline.1 passage
• Association Between Breastfeeding and Postpartum Multiple Sclerosis Relapses: A Systematic Review and Meta-analysis.1 passage
• Association Between Cardiovascular Disease and Long-term Exposure to Air Pollution With the Risk of Dementia.1 passage
• Association Between Caregiver Depression and Emergency Department Use Among Patients With Dementia.1 passage
• Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.1 passage
• Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later.1 passage
• Association Between Cigarette Smoking and Multiple Sclerosis: A Review.1 passage
• Association Between Cirrhosis and Stroke in a Nationally Representative Cohort.1 passage
• Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease.1 passage
• Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis.1 passage
• Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis.1 passage
• Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease.1 passage
• Association Between Globular Glial Tauopathies and Frontotemporal Dementia-Expanding the Spectrum of Gliocentric Disorders: A Review.1 passage
• Association Between Hypodensities Detected by Computed Tomography and Hematoma Expansion in Patients With Intracerebral Hemorrhage.1 passage
• Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom.1 passage
• Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy-Related Inflammation.1 passage
• Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up: A Nested Multisite Cohort Study.1 passage
• Association Between Intracerebral Hemorrhage and Subsequent Arterial Ischemic Events in Participants From 4 Population-Based Cohort Studies.1 passage
• Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.1 passage
• Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial.1 passage
• Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.1 passage
• Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.1 passage
• Association Between Microinfarcts and Blood Pressure Trajectories.1 passage
• Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.1 passage
• Association Between Migraine and Cervical Artery Dissection: The Italian Project on Stroke in Young Adults.1 passage
• Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease.1 passage
• Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.1 passage
• Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy.1 passage
• Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.1 passage
• Association Between Post-Dural Puncture Headache After Neuraxial Anesthesia in Childbirth and Intracranial Subdural Hematoma.1 passage
• Association Between Pregnancy and Perinatal Outcomes Among Women With Epilepsy.1 passage
• Association Between Prehospital Tranexamic Acid Administration and Outcomes of Severe Traumatic Brain Injury.1 passage
• Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children.1 passage
• Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died.1 passage
• Association Between Serum Calcium Level and Extent of Bleeding in Patients With Intracerebral Hemorrhage.1 passage
• Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.1 passage
• Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years.1 passage
• Association Between Statin Use and Risk of Dementia After a Concussion.1 passage
• Association Between Subclinical Cardiac Biomarkers and Clinically Manifest Cardiac Diseases With Cortical Cerebral Microinfarcts.1 passage
• Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding.1 passage
• Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.1 passage
• Association Between Treatment Progression, Disease Refractoriness, and Burden of Illness Among Hospitalized Patients With Status Epilepticus.1 passage
• Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events.1 passage
• Association Between Unrecognized Myocardial Infarction and Cerebral Infarction on Magnetic Resonance Imaging.1 passage
• Association of 3.0-T brain magnetic resonance imaging biomarkers with cognitive function in the Dallas Heart Study.1 passage
• Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.1 passage
• Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.1 passage
• Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project.1 passage
• Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study.1 passage
• Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE).1 passage
• Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.1 passage
• Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection.1 passage
• Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis.1 passage
• Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.1 passage
• Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.1 passage
• Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.1 passage
• Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.1 passage
• Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.1 passage
• Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration.1 passage
• Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial.1 passage
• Association of Blood Pressure, Blood Glucose, and Temperature With Neurological Outcome After Childhood Stroke.1 passage
• Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease.1 passage
• Association of Bone Mineral Density With the Risk of Intracranial Aneurysm.1 passage
• Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.1 passage
• Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease.1 passage
• Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.1 passage
• Association of CAG Repeats With Long-term Progression in Huntington Disease.1 passage
• Association of Cardiac Hemodynamic Factors With Severity of White Matter Hyperintensities in Chronic Valvular Heart Disease.1 passage
• Association of Cavum Septum Pellucidum and Cavum Vergae With Cognition, Mood, and Brain Volumes in Professional Fighters.1 passage
• Association of Cerebral Microbleeds With Cognitive Decline and Dementia.1 passage
• Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.1 passage
• Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.1 passage
• Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.1 passage
• Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery: Results From the CAPACITY and ARCADIAN Studies.1 passage
• Association of Childhood Body Mass Index and Change in Body Mass Index With First Adult Ischemic Stroke.1 passage
• Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.1 passage
• Association of Circadian Abnormalities in Older Adults With an Increased Risk of Developing Parkinson Disease.1 passage
• Association of Closed-Loop Brain Stimulation Neurophysiological Features With Seizure Control Among Patients With Focal Epilepsy.1 passage
• Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia.1 passage
• Association of Collateral Blood Vessels Detected by Arterial Spin Labeling Magnetic Resonance Imaging With Neurological Outcome After Ischemic Stroke.1 passage
• Association of Concussion Symptoms With Testosterone Levels and Erectile Dysfunction in Former Professional US-Style Football Players.1 passage
• Association of Concussion With the Risk of Suicide: A Systematic Review and Meta-analysis.1 passage
• Association of Conflicts of Interest for Public Speakers for the Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug Administration With Their Statements.1 passage
• Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.1 passage
• Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.1 passage
• Association of Cortical Stimulation-Induced Seizure With Surgical Outcome in Patients With Focal Drug-Resistant Epilepsy.1 passage
• Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.1 passage
• Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.1 passage
• Association of Delirium With Long-term Cognitive Decline: A Meta-analysis.1 passage
• Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years.1 passage
• Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis.1 passage
• Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies.1 passage
• Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.1 passage
• Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment: Results From the Gait and Brain Study.1 passage
• Association of Early-Life Cognitive Enrichment With Alzheimer Disease Pathological Changes and Cognitive Decline.1 passage
• Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.1 passage
• Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community.1 passage
• Association of Environmental Toxins With Amyotrophic Lateral Sclerosis.1 passage
• Association of Enzyme-Inducing Antiseizure Drug Use With Long-term Cardiovascular Disease.1 passage
• Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia.1 passage
• Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging.1 passage
• Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.1 passage
• Association of Field Position and Career Length With Risk of Neurodegenerative Disease in Male Former Professional Soccer Players.1 passage
• Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero.1 passage
• Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.1 passage
• Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults.1 passage
• Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.1 passage
• Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.1 passage
• Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.1 passage
• Association of Hypercapnia and Hypercapnic Acidosis With Clinical Outcomes in Mechanically Ventilated Patients With Cerebral Injury.1 passage
• Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.1 passage
• Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up: A Nested Multisite Cohort Study.1 passage
• Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.1 passage
• Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.1 passage
• Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.1 passage
• Association of Intensive Blood Pressure Reduction With Risk of Hematoma Expansion in Patients With Deep Intracerebral Hemorrhage.1 passage
• Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial.1 passage
• Association of Intracranial Atherosclerotic Disease With Brain β-Amyloid Deposition: Secondary Analysis of the ARIC Study.1 passage
• Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis.1 passage
• Association of Intracranial Pressure and Spontaneous Retinal Venous Pulsation.1 passage
• Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.1 passage
• Association of JNC-8 and SPRINT Systolic Blood Pressure Levels With Cognitive Function and Related Racial Disparity.1 passage
• Association of Key Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease With Hematoma Volume and Expansion in Patients With Lobar and Deep Intracerebral Hemorrhage.1 passage
• Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.1 passage
• Association of Late-Onset Unprovoked Seizures of Unknown Etiology With the Risk of Developing Dementia in Older Veterans.1 passage
• Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.1 passage
• Association of Levels of Specialized Care With Risk of Premature Mortality in Patients With Epilepsy.1 passage
• Association of Lifespan Cognitive Reserve Indicator With Dementia Risk in the Presence of Brain Pathologies.1 passage
• Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.1 passage
• Association of Long-term Opioid Therapy With Functional Status, Adverse Outcomes, and Mortality Among Patients With Polyneuropathy.1 passage
• Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship.1 passage
• Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.1 passage
• Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.1 passage
• Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.1 passage
• Association of Medication Nonadherence Among Adult Survivors of Stroke After Implementation of the US Affordable Care Act.1 passage
• Association of Miglustat With Swallowing Outcomes in Niemann-Pick Disease, Type C1.1 passage
• Association of Mild Traumatic Brain Injury With and Without Loss of Consciousness With Dementia in US Military Veterans.1 passage
• Association of Mutations in TBK1 With Sporadic and Familial Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.1 passage
• Association of NO2 and Other Air Pollution Exposures With the Risk of Parkinson Disease.1 passage
• Association of NOTCH2NLC Repeat Expansions With Parkinson Disease.1 passage
• Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume.1 passage
• Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.1 passage
• Association of Obesity With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in Children.1 passage
• Association of Optic Pathways and Brain Structure With Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia-Reply.1 passage
• Association of Optic Pathways and Brain Structure With Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia.1 passage
• Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism.1 passage
• Association of Periodic and Rhythmic Electroencephalographic Patterns With Seizures in Critically Ill Patients.1 passage
• Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains.1 passage
• Association of Pharmacological Interventions With Symptom Burden Reduction in Patients With Mild Traumatic Brain Injury: A Systematic Review.1 passage
• Association of Physical Activity, Including Amount and Maintenance, With All-Cause Mortality in Parkinson Disease.1 passage
• Association of Piriform Cortex Resection With Surgical Outcomes in Patients With Temporal Lobe Epilepsy.1 passage
• Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.1 passage
• Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.1 passage
• Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies.1 passage
• Association of Playing High School Football With Cognition and Mental Health Later in Life.1 passage
• Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.1 passage
• Association of Pregnancy With the Onset of Clinically Isolated Syndrome.1 passage
• Association of Prognostic Factors and Immunosuppressive Treatment With Long-term Outcomes in Neurosarcoidosis.1 passage
• Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.1 passage
• Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.1 passage
• Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.1 passage
• Association of Racial Residential Segregation Throughout Young Adulthood and Cognitive Performance in Middle-aged Participants in the CARDIA Study.1 passage
• Association of Rapid Eye Movement Sleep With Mortality in Middle-aged and Older Adults.1 passage
• Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.1 passage
• Association of Reperfusion After Thrombolysis With Clinical Outcome Across the 4.5- to 9-Hours and Wake-up Stroke Time Window: A Meta-Analysis of the EXTEND and EPITHET Randomized Clinical Trials.1 passage
• Association of Reperfusion With Brain Edema in Patients With Acute Ischemic Stroke: A Secondary Analysis of the MR CLEAN Trial.1 passage
• Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis.1 passage
• Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome.1 passage
• Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline: A Study Using Optical Coherence Tomography.1 passage
• Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study.1 passage
• Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis.1 passage
• Association of Seizure Spread With Surgical Failure in Epilepsy.1 passage
• Association of Selective Serotonin Reuptake Inhibitor Use After Intracerebral Hemorrhage With Hemorrhage Recurrence and Depression Severity.1 passage
• Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage.1 passage
• Association of Seropositivity to Borrelia burgdorferi With the Risk of Neuropsychiatric Disorders and Functional Decline in Older Adults: The Aging Multidisciplinary Investigation Study.1 passage
• Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.1 passage
• Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis.1 passage
• Association of Severe Hydrocephalus With Congenital Zika Syndrome.1 passage
• Association of Short and Long Sleep Duration With Amyloid-β Burden and Cognition in Aging.1 passage
• Association of Sickle Cell Trait With Ischemic Stroke Among African Americans: A Meta-analysis.1 passage
• Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical Trial.1 passage
• Association of Sleep-Disordered Breathing With Cognitive Function and Risk of Cognitive Impairment: A Systematic Review and Meta-analysis.1 passage
• Association of Stress-Related Disorders With Subsequent Neurodegenerative Diseases.1 passage
• Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.1 passage
• Association of Targeting Vascular Risk Factors With a Reduction in Dementia Incidence in Old Age: Secondary Analysis of the Prevention of Dementia by Intensive Vascular care (preDIVA) Randomized Clinical Trial.1 passage
• Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial.1 passage
• Association of Time From Stroke Onset to Groin Puncture With Quality of Reperfusion After Mechanical Thrombectomy: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials.1 passage
• Association of Time Since Injury to the First Clinic Visit With Recovery Following Concussion.1 passage
• Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus.1 passage
• Association of Tourette Syndrome and Chronic Tic Disorder With Cervical Spine Disorders and Related Neurological Complications.1 passage
• Association of Tourette Syndrome and Chronic Tic Disorder With Metabolic and Cardiovascular Disorders.1 passage
• Association of Tourette Syndrome and Chronic Tic Disorders With Objective Indicators of Educational Attainment: A Population-Based Sibling Comparison Study.1 passage
• Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings.1 passage
• Association of Unintended Pregnancy With Spontaneous Fetal Loss in Women With Epilepsy: Findings of the Epilepsy Birth Control Registry.1 passage
• Association of Variants in PINX1 and TREM2 With Late-Onset Alzheimer Disease.1 passage
• Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis.1 passage
• Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization.1 passage
• Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.1 passage
• Association of White Matter Hyperintensities With Pathology and Progression of Parkinsonism in Aging.1 passage
• Association of White Matter Rarefaction, Arteriolosclerosis, and Tau With Dementia in Chronic Traumatic Encephalopathy.1 passage
• Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis.1 passage
• Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration.1 passage
• Association of a Novel ACTA1 Mutation With a Dominant Progressive Scapuloperoneal Myopathy in an Extended Family.1 passage
• Association of a Primary Stroke Center Protocol for Suspected Stroke by Large-Vessel Occlusion With Efficiency of Care and Patient Outcomes.1 passage
• Association of an Electroencephalography-Based Risk Score With Seizure Probability in Hospitalized Patients.1 passage
• Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.1 passage
• Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.1 passage
• Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.1 passage
• Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.1 passage
• Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.1 passage
• Associations Between Migraine and Type 2 Diabetes in Women: Findings From the E3N Cohort Study.1 passage
• Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.1 passage
• Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort.1 passage
• Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.1 passage
• Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.1 passage
• Associations of Apolipoprotein E ε4 Genotype and Ball Heading With Verbal Memory in Amateur Soccer Players.1 passage
• Associations of Physical Activity and β-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults.1 passage
• Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease.1 passage
• Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis.1 passage
• Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results.1 passage
• Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis.1 passage
• Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society.1 passage
• Axonal ion channel dysfunction in c9orf72 familial amyotrophic lateral sclerosis.1 passage
• Basal Ganglia Circuits as Targets for Neuromodulation in Parkinson Disease.1 passage
• Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia: A Randomized Clinical Trial.1 passage
• Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial.1 passage
• Blood Pressure Thresholds and Neurologic Outcomes After Endovascular Therapy for Acute Ischemic Stroke: An Analysis of Individual Patient Data From 3 Randomized Clinical Trials.1 passage
• Blood-Borne Revitalization of the Aged Brain.1 passage
• Brain Calcifications in Adult-Onset Genetic Leukoencephalopathies: A Review.1 passage
• Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.1 passage
• Brain Stimulation for Torsion Dystonia.1 passage
• Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study.1 passage
• Care and Outcomes of Patients With In-Hospital Stroke.1 passage
• Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial.1 passage
• Cerebral microbleeds and early recurrent stroke after transient ischemic attack: results from the Korean Transient Ischemic Attack Expression Registry.1 passage
• Cerebrospinal Fluid Biomarkers in Postconcussion Syndrome: Measuring Neuronal Injury and Distinguishing Individuals at Risk for Persistent Postconcussion Syndrome or Chronic Traumatic Encephalopathy.1 passage
• Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.1 passage
• Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease.1 passage
• Challenges to Translation and the Hippocratic Oath by Premature Termination of Spinal Cord Stem Cell-Based Trials.1 passage
• Change in Mortality of Generalized Convulsive Status Epilepticus in High-Income Countries Over Time: A Systematic Review and Meta-analysis.1 passage
• Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.1 passage
• Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.1 passage
• Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.1 passage
• Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria.1 passage
• Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.1 passage
• Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes.1 passage
• Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.1 passage
• Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.1 passage
• Characterizing Demographic, Racial, and Geographic Diversity in Dementia Research: A Systematic Review.1 passage
• Chemogenetics-A Transformational and Translational Platform.1 passage
• Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.1 passage
• Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing.1 passage
• Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease.1 passage
• Clinical Aspects of Glucose Transporter Type 1 Deficiency: Information From a Global Registry.1 passage
• Clinical Characteristics and Functional Motor Outcomes of Enterovirus 71 Neurological Disease in Children.1 passage
• Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.1 passage
• Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.1 passage
• Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study.1 passage
• Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.1 passage
• Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion.1 passage
• Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.1 passage
• Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.1 passage
• Clinical Features of Alzheimer Disease With and Without Lewy Bodies.1 passage
• Clinical Features of Guillain-Barré Syndrome With vs Without Zika Virus Infection, Puerto Rico, 2016.1 passage
• Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy.1 passage
• Clinical Imaging Factors Associated With Infarct Progression in Patients With Ischemic Stroke During Transfer for Mechanical Thrombectomy.1 passage
• Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis.1 passage
• Clinical Phenotype and Segregation of Mitochondrial 3243A>G Mutation in 2 Pairs of Monozygotic Twins.1 passage
• Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy.1 passage
• Clinical Presentation, Investigation Findings, and Treatment Outcomes of Spontaneous Intracranial Hypotension Syndrome: A Systematic Review and Meta-analysis.1 passage
• Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis.1 passage
• Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.1 passage
• Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease.1 passage
• Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.1 passage
• Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.1 passage
• Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.1 passage
• Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.1 passage
• Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.1 passage
• Clinical, Genetic, and Radiological Features of Extrapyramidal Movement Disorders in Mitochondrial Disease.1 passage
• Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.1 passage
• Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.1 passage
• Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes.1 passage
• Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28.1 passage
• Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis.1 passage
• Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study.1 passage
• Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults.1 passage
• Combined Intravenous Thrombolysis and Thrombectomy vs Thrombectomy Alone for Acute Ischemic Stroke: A Pooled Analysis of the SWIFT and STAR Studies.1 passage
• Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease.1 passage
• Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.1 passage
• Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.1 passage
• Comparative Effectiveness of Carotid Endarterectomy vs Initial Medical Therapy in Patients With Asymptomatic Carotid Stenosis.1 passage
• Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis.1 passage
• Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau-Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers.1 passage
• Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis.1 passage
• Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial.1 passage
• Comparison of Clinical Care and In-Hospital Outcomes of Asian American and White Patients With Acute Ischemic Stroke.1 passage
• Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial.1 passage
• Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial.1 passage
• Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.1 passage
• Comparison of Prehospital Scales for Predicting Large Anterior Vessel Occlusion in the Ambulance Setting.1 passage
• Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.1 passage
• Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.1 passage
• Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.1 passage
• Compensation Strategies for Gait Impairments in Parkinson Disease: A Review.1 passage
• Complex and Dynamic Chromosomal Rearrangements in a Family With Seemingly Non-Mendelian Inheritance of Dopa-Responsive Dystonia.1 passage
• Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults.1 passage
• Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.1 passage
• Congenital Zika Virus Infection: Beyond Neonatal Microcephaly.1 passage
• Continuous vs Routine Electroencephalogram in Critically Ill Adults With Altered Consciousness and No Recent Seizure: A Multicenter Randomized Clinical Trial.1 passage
• Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.1 passage
• Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort.1 passage
• Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.1 passage
• Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.1 passage
• Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.1 passage
• Cortical Structures Associated With Human Blood Pressure Control.1 passage
• Criminal behavior in frontotemporal dementia and Alzheimer disease.1 passage
• Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.1 passage
• Current Understanding and Gaps in Research of Carotid Webs in Ischemic Strokes: A Review.1 passage
• DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease.1 passage
• Dancing Dorsal Quadrilaterals: A Novel Peripherally Induced Movement Disorder.1 passage
• Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging.1 passage
• Deep intronic GBE1 mutation in manifesting heterozygous patients with adult polyglucosan body disease.1 passage
• Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.1 passage
• Definition and Implications of the Preventable Stroke.1 passage
• Depression Outcomes Among Patients Treated With Fluoxetine for Stroke Recovery: The AFFINITY Randomized Clinical Trial.1 passage
• Derivation and External Validation of a Scoring System for Predicting Fracture Risk After Ischemic Stroke in a Canadian Cohort.1 passage
• Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid.1 passage
• Development and Validation of a New Scoring System to Predict Survival in Patients With Myotonic Dystrophy Type 1.1 passage
• Development and Validation of a Prognostic Model of Swallowing Recovery and Enteral Tube Feeding After Ischemic Stroke.1 passage
• Development and Validation of the 5-SENSE Score to Predict Focality of the Seizure-Onset Zone as Assessed by Stereoelectroencephalography.1 passage
• Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).1 passage
• Development of Expert-Level Automated Detection of Epileptiform Discharges During Electroencephalogram Interpretation.1 passage
• Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.1 passage
• Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.1 passage
• Developmental Trajectories of Infants With Multiplex Family Risk for Autism: A Baby Siblings Research Consortium Study.1 passage
• Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.1 passage
• Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine.1 passage
• Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.1 passage
• Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples.1 passage
• Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review.1 passage
• Diagnostic Challenges and Clinical Characteristics of Hepatitis E Virus-Associated Guillain-Barré Syndrome.1 passage
• Diagnostic Errors in Initial Misdiagnosis of Optic Nerve Sheath Meningiomas.1 passage
• Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.1 passage
• Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.1 passage
• Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.1 passage
• Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.1 passage
• Diagnostic value of somatosensory evoked potential changes during carotid endarterectomy: a systematic review and meta-analysis.1 passage
• Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.1 passage
• Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.1 passage
• Direct to Angiography Suite Without Stopping for Computed Tomography Imaging for Patients With Acute Stroke: A Randomized Clinical Trial.1 passage
• Direct to Angiography vs Repeated Imaging Approaches in Transferred Patients Undergoing Endovascular Thrombectomy.1 passage
• Disability Trajectories Before and After Stroke and Myocardial Infarction: The Cardiovascular Health Study.1 passage
• Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.1 passage
• Discerning the Role of Autoimmunity and Autoantibodies in Epilepsy: A Review.1 passage
• Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.1 passage
• Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network Degeneration.1 passage
• Distribution and Quantity of Sites of John Cunningham Virus Persistence in Immunologically Healthy Patients: Correlation With John Cunningham Virus Antibody and Urine John Cunningham Virus DNA.1 passage
• Distributional Validity and Prognostic Power of the National Institutes of Health Stroke Scale in US Administrative Claims Data.1 passage
• Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial.1 passage
• Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.1 passage
• Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis.1 passage
• Duration and Pathologic Correlates of Lewy Body Disease.1 passage
• Dynamic Changes in White Matter Hyperintensities in Reversible Cerebral Vasoconstriction Syndrome.1 passage
• Early Clinical Predictors of 5-Year Outcome After Concussive Blast Traumatic Brain Injury.1 passage
• Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.1 passage
• Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years.1 passage
• Early-Onset Alzheimer Disease and Candidate Risk Genes Involved in Endolysosomal Transport.1 passage
• Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial.1 passage
• Effect of Cerebellar Stimulation on Gait and Balance Recovery in Patients With Hemiparetic Stroke: A Randomized Clinical Trial.1 passage
• Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease.1 passage
• Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial.1 passage
• Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.1 passage
• Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial.1 passage
• Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.1 passage
• Effect of Gabapentin vs Pregabalin on Pain Intensity in Adults With Chronic Sciatica: A Randomized Clinical Trial.1 passage
• Effect of General Anesthesia and Conscious Sedation During Endovascular Therapy on Infarct Growth and Clinical Outcomes in Acute Ischemic Stroke: A Randomized Clinical Trial.1 passage
• Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease.1 passage
• Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial.1 passage
• Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial.1 passage
• Effect of In-Hospital Remote Ischemic Perconditioning on Brain Infarction Growth and Clinical Outcomes in Patients With Acute Ischemic Stroke: The RESCUE BRAIN Randomized Clinical Trial.1 passage
• Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.1 passage
• Effect of Intensive Patient Education vs Placebo Patient Education on Outcomes in Patients With Acute Low Back Pain: A Randomized Clinical Trial.1 passage
• Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial.1 passage
• Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial.1 passage
• Effect of Motor Skill Training in Functional Activities vs Strength and Flexibility Exercise on Function in People With Chronic Low Back Pain: A Randomized Clinical Trial.1 passage
• Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.1 passage
• Effect of Pain Neuroscience Education Combined With Cognition-Targeted Motor Control Training on Chronic Spinal Pain: A Randomized Clinical Trial.1 passage
• Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis.1 passage
• Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.1 passage
• Effect of Smoking Cessation on Multiple Sclerosis Prognosis.1 passage
• Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease: The PRESERVE Randomized Clinical Trial.1 passage
• Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke: A Randomized Clinical Trial and Meta-analysis.1 passage
• Effect of Stroke Education Pamphlets vs a 12-Minute Culturally Tailored Stroke Film on Stroke Preparedness Among Black and Hispanic Churchgoers: A Cluster Randomized Clinical Trial.1 passage
• Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial.1 passage
• Effect of a Quality Improvement Intervention on Adherence to Therapies for Patients With Acute Ischemic Stroke and Transient Ischemic Attack: A Cluster Randomized Clinical Trial.1 passage
• Effect of an Enhanced Paramedic Acute Stroke Treatment Assessment on Thrombolysis Delivery During Emergency Stroke Care: A Cluster Randomized Clinical Trial.1 passage
• Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.1 passage
• Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial.1 passage
• Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.1 passage
• Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial.1 passage
• Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy.1 passage
• Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis.1 passage
• Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.1 passage
• Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome: The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry.1 passage
• Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial.1 passage
• Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.1 passage
• Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders: A Systematic Review and Meta-analysis.1 passage
• Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.1 passage
• Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes.1 passage
• Efficacy of Home-Based Telerehabilitation vs In-Clinic Therapy for Adults After Stroke: A Randomized Clinical Trial.1 passage
• Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.1 passage
• Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy: A Randomized Clinical Trial.1 passage
• Efficacy of a Discharge Educational Strategy vs Standard Discharge Care on Reduction of Vascular Risk in Patients With Stroke and Transient Ischemic Attack: The DESERVE Randomized Clinical Trial.1 passage
• Efforts in Epilepsy Prevention in the Last 40 Years: Lessons From a Large Nationwide Study.1 passage
• Electroencephalographic Periodic Discharges and Frequency-Dependent Brain Tissue Hypoxia in Acute Brain Injury.1 passage
• Electronic Dura Mater Meddling in the Central Nervous System.1 passage
• Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease: A Review.1 passage
• Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease: A Review.1 passage
• Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review.1 passage
• Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge.1 passage
• Endovascular Stroke Treatment Outcomes After Patient Selection Based on Magnetic Resonance Imaging and Clinical Criteria.1 passage
• Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the Middle Cerebral Artery M2 Segment.1 passage
• Endovascular Thrombectomy as a Means to Improve Survival in Acute Ischemic Stroke: A Meta-analysis.1 passage
• Endovascular Treatment After Stroke Due to Large Vessel Occlusion for Patients Presenting Very Late From Time Last Known Well.1 passage
• Endovascular Treatment for Patients With Acute Stroke Who Have a Large Ischemic Core and Large Mismatch Imaging Profile.1 passage
• Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.1 passage
• Estimates of the Association of Dementia With US Mortality Levels Using Linked Survey and Mortality Records.1 passage
• Ethical Challenges of Risk, Informed Consent, and Posttrial Responsibilities in Human Research With Neural Devices: A Review.1 passage
• Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England.1 passage
• Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals.1 passage
• Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.1 passage
• Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.1 passage
• Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.1 passage
• Evaluation of a New Criterion for Detecting Prion Disease With Diffusion Magnetic Resonance Imaging.1 passage
• Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort.1 passage
• Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.1 passage
• Evidence on Use of Neuroimaging for Surgical Treatment of Temporal Lobe Epilepsy: A Systematic Review.1 passage
• Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.1 passage
• Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.1 passage
• Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses.1 passage
• Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis.1 passage
• Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.1 passage
• Exploring the Association Between Rosacea and Parkinson Disease: A Danish Nationwide Cohort Study.1 passage
• Extracellular Mitochondria for Therapy and Diagnosis in Acute Central Nervous System Injury.1 passage
• Factors Associated With 8-Year Mortality in Older Patients With Cerebral Small Vessel Disease: The Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study.1 passage
• Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.1 passage
• Factors Associated With Risk of Recurrent Transient Global Amnesia.1 passage
• Factors Contributing to Major Neurological Complications From Vein of Galen Malformation Embolization.1 passage
• Factors associated with the onset and persistence of post-lumbar puncture headache.1 passage
• Family History of Cluster Headache: A Systematic Review.1 passage
• Fatal Powassan Encephalitis (Deer Tick Virus, Lineage II) in a Patient With Fever and Orchitis Receiving Rituximab.1 passage
• Feasibility, Safety, and Outcome of Endovascular Recanalization in Childhood Stroke: The Save ChildS Study.1 passage
• Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.1 passage
• Female- and Male-Specific Risk Factors for Stroke: A Systematic Review and Meta-analysis.1 passage
• Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.1 passage
• Fertility and Birth Outcomes in Women With Epilepsy Seeking Pregnancy.1 passage
• Fibromuscular Dysplasia and Its Neurologic Manifestations: A Systematic Review.1 passage
• Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial.1 passage
• Findings of Impaired Hearing in Patients With Nonfluent/Agrammatic Variant Primary Progressive Aphasia.1 passage
• Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy.1 passage
• Flow Diversion for the Treatment of Intracranial Aneurysms.1 passage
• Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment: Results From the UK NorthStar Database.1 passage
• Frequency of Intracranial Hemorrhage With Low-Dose Aspirin in Individuals Without Symptomatic Cardiovascular Disease: A Systematic Review and Meta-analysis.1 passage
• Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease.1 passage
• Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.1 passage
• Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.1 passage
• Frequency, Predictors, and Outcomes of Prehospital and Early Postarrival Neurological Deterioration in Acute Stroke: Exploratory Analysis of the FAST-MAG Randomized Clinical Trial.1 passage
• Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.1 passage
• Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial.1 passage
• Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI Study.1 passage
• General Anesthesia vs Local Anesthesia in Microelectrode Recording-Guided Deep-Brain Stimulation for Parkinson Disease: The GALAXY Randomized Clinical Trial.1 passage
• Genetic Modifiers of Age at Onset in Carriers of the G206A Mutation in PSEN1 With Familial Alzheimer Disease Among Caribbean Hispanics.1 passage
• Genome Editing of Monogenic Neuromuscular Diseases: A Systematic Review.1 passage
• Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.1 passage
• Genomics of Alzheimer Disease: A Review.1 passage
• Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis.1 passage
• Globus Pallidus Interna or Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease: A Review.1 passage
• Gradually Progressive Spastic Ataxia in a Young Man: Steadily Unsteady.1 passage
• Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.1 passage
• Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US: A Review.1 passage
• Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic Stroke: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials.1 passage
• Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals.1 passage
• Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.1 passage
• High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews.1 passage
• High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.1 passage
• Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.1 passage
• Home Health Management of Parkinson Disease Deep Brain Stimulation: A Randomized Clinical Trial.1 passage
• Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled Trial.1 passage
• Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab.1 passage
• Huntingtin-Lowering Therapies for Huntington Disease: A Review of the Evidence of Potential Benefits and Risks.1 passage
• Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.1 passage
• Hypoxic-Ischemic Encephalopathy Evaluated by Brain Autopsy and Neuroprognostication After Cardiac Arrest.1 passage
• Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets.1 passage
• Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.1 passage
• Identification of a Loss-of-Function Mutation in the Context of Glutaminase Deficiency and Neonatal Epileptic Encephalopathy.1 passage
• Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.1 passage
• Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis.1 passage
• Imaging Correlates of Memory and Concussion History in Retired National Football League Athletes.1 passage
• Imaging Parameters and Recurrent Cerebrovascular Events in Patients With Minor Stroke or Transient Ischemic Attack.1 passage
• Imaging of Glial Cell Activation and White Matter Integrity in Brains of Active and Recently Retired National Football League Players.1 passage
• Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis.1 passage
• Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy.1 passage
• Impaired Synaptic Development, Maintenance, and Neuromuscular Transmission in LRP4-Related Myasthenia.1 passage
• Implementation of a Prehospital Stroke Triage System Using Symptom Severity and Teleconsultation in the Stockholm Stroke Triage Study.1 passage
• Implementing a mobile stroke unit program in the United States: why, how, and how much?1 passage
• Incidence of Recurrence in Posterior Circulation Childhood Arterial Ischemic Stroke.1 passage
• Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals.1 passage
• Indirect measures of arterial stiffness and cognitive performance in individuals without traditional vascular risk factors or disease.1 passage
• Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.1 passage
• Inflammation and neuroprotection in traumatic brain injury.1 passage
• Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.1 passage
• Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.1 passage
• Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.1 passage
• Interpreting Genetic Variants in Titin in Patients With Muscle Disorders.1 passage
• Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab.1 passage
• Interrater Reliability of Experts in Identifying Interictal Epileptiform Discharges in Electroencephalograms.1 passage
• Intractable Epilepsy and Progressive Cognitive Decline in a Young Man.1 passage
• Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis.1 passage
• Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.1 passage
• Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines.1 passage
• Large Perivascular Spaces Visible on Magnetic Resonance Imaging, Cerebral Small Vessel Disease Progression, and Risk of Dementia: The Age, Gene/Environment Susceptibility-Reykjavik Study.1 passage
• Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial.1 passage
• Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis.1 passage
• Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis.1 passage
• Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.1 passage
• Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.1 passage
• Long-term Risk of Parkinson Disease Following Influenza and Other Infections.1 passage
• Long-term Socioeconomic Outcomes Associated With Pediatric-Onset Multiple Sclerosis.1 passage
• Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder.1 passage
• Longitudinal Assessment of Small Fiber Neuropathy: Evidence of a Non-Length-Dependent Distal Axonopathy.1 passage
• Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.1 passage
• Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.1 passage
• Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.1 passage
• Loss of Consciousness at Onset of Subarachnoid Hemorrhage as an Important Marker of Early Brain Injury.1 passage
• Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial.1 passage
• Management of Gait Impairments in Chronic Unilateral Upper Motor Neuron Lesions: A Review.1 passage
• Management of Tiny Unruptured Intracranial Aneurysms: A Comparative Effectiveness Analysis.1 passage
• Mapping the "Depression Switch" During Intraoperative Testing of Subcallosal Cingulate Deep Brain Stimulation.1 passage
• Mapping the Supratentorial Cerebral Arterial Territories Using 1160 Large Artery Infarcts.1 passage
• Massive CAG repeat expansion and somatic instability in maternally transmitted infantile spinocerebellar ataxia type 7.1 passage
• Maternal Body Mass Index in Early Pregnancy and Risk of Epilepsy in Offspring.1 passage
• Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps.1 passage
• Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review.1 passage
• Media Dissemination of the Montreal Cognitive Assessment After President Donald Trump's Medical Evaluation.1 passage
• Mediation of the Relationship Between Endovascular Therapy and Functional Outcome by Follow-up Infarct Volume in Patients With Acute Ischemic Stroke.1 passage
• Medical Attention Seeking After Transient Ischemic Attack and Minor Stroke Before and After the UK Face, Arm, Speech, Time (FAST) Public Education Campaign: Results From the Oxford Vascular Study.1 passage
• Medical Management vs Mechanical Thrombectomy for Mild Strokes: An International Multicenter Study and Systematic Review and Meta-analysis.1 passage
• Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.1 passage
• Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial.1 passage
• Microbleeds, Mortality, and Stroke in Alzheimer Disease: The MISTRAL Study.1 passage
• Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.1 passage
• Modeling Stroke Patient Transport for All Patients With Suspected Large-Vessel Occlusion.1 passage
• Modulation of GluN3A expression in Huntington disease: a new n-methyl-D-aspartate receptor-based therapeutic approach?1 passage
• Molecular Basis and Clinical Overview of McLeod Syndrome Compared With Other Neuroacanthocytosis Syndromes: A Review.1 passage
• Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome.1 passage
• Monitored Anesthesia Care vs Intubation for Vertebrobasilar Stroke Endovascular Therapy.1 passage
• Monitoring Clinical Course and Treatment Response in Chronic Inflammatory Demyelinating Polyneuropathy During Routine Care: A Review of Clinical and Laboratory Assessment Measures.1 passage
• Mortality and Morbidity During Delivery Hospitalization Among Pregnant Women With Epilepsy in the United States.1 passage
• Mutation in CPT1C Associated With Pure Autosomal Dominant Spastic Paraplegia.1 passage
• Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.1 passage
• National Patterns of Carotid Revascularization Before and After the Carotid Revascularization Endarterectomy vs Stenting Trial (CREST).1 passage
• Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases.1 passage
• Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease.1 passage
• Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury.1 passage
• Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.1 passage
• Neurocritical Care Outcomes, Research, and Technology: A Review.1 passage
• Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes.1 passage
• Neuroelectronics and Biooptics: Closed-Loop Technologies in Neurological Disorders.1 passage
• Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design.1 passage
• Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.1 passage
• Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein.1 passage
• Neurologic Complications Associated With the Zika Virus in Brazilian Adults.1 passage
• Neurologic Function and Health-Related Quality of Life in Patients Following Targeted Temperature Management at 33°C vs 36°C After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.1 passage
• Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome.1 passage
• Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.1 passage
• Neurologic Phenotypes Associated With Mutations in RTN4IP1 (OPA10) in Children and Young Adults.1 passage
• Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children.1 passage
• Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology.1 passage
• Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies.1 passage
• Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.1 passage
• Neuropathologic Associations of Learning and Memory in Primary Progressive Aphasia.1 passage
• Neuropsychological Outcomes of Children 1 Year After Pediatric Cardiac Arrest: Secondary Analysis of 2 Randomized Clinical Trials.1 passage
• New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.1 passage
• New Horizons in Pharmacologic Therapy for Secondary Stroke Prevention.1 passage
• Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.1 passage
• Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion.1 passage
• Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.1 passage
• Nonmydriatic ocular fundus photography in neurologic emergencies.1 passage
• Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis.1 passage
• Novel methods and technologies for 21st-century clinical trials: a review.1 passage
• Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts.1 passage
• Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.1 passage
• Opportunities for Prevention of Concussion and Repetitive Head Impact Exposure in College Football Players: A Concussion Assessment, Research, and Education (CARE) Consortium Study.1 passage
• Optic Nerve Infiltration in Primary Central Nervous System Lymphoma.1 passage
• Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.1 passage
• Outcomes after carotid artery stenting in Medicare beneficiaries, 2005 to 2009.1 passage
• Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.1 passage
• Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.1 passage
• Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study.1 passage
• Outcomes of Hypothermia in Addition to Decompressive Hemicraniectomy in Treatment of Malignant Middle Cerebral Artery Stroke: A Randomized Clinical Trial.1 passage
• Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial.1 passage
• Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial.1 passage
• Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.1 passage
• Participation in Get With The Guidelines-Stroke and Its Association With Quality of Care for Stroke.1 passage
• Participation in Physical Activity and Risk for Amyotrophic Lateral Sclerosis Mortality Among Postmenopausal Women.1 passage
• Pathological Computed Tomography Features Associated With Adverse Outcomes After Mild Traumatic Brain Injury: A TRACK-TBI Study With External Validation in CENTER-TBI.1 passage
• Pathophysiologic Mechanisms of Cerebral Ischemia and Diffusion Hypoxia in Traumatic Brain Injury.1 passage
• Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.1 passage
• Patterns of Cortical Synchronization in Isolated Dystonia Compared With Parkinson Disease.1 passage
• Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.1 passage
• Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status.1 passage
• Peripheral Total Tau in Military Personnel Who Sustain Traumatic Brain Injuries During Deployment.1 passage
• Pharmacotherapy for Pain in a Family With Inherited Erythromelalgia Guided by Genomic Analysis and Functional Profiling.1 passage
• Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.1 passage
• Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study.1 passage
• Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.1 passage
• Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial.1 passage
• Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.1 passage
• Placebo Effects on the Neurologic Pain Signature: A Meta-analysis of Individual Participant Functional Magnetic Resonance Imaging Data.1 passage
• Plasma Coenzyme Q10 Levels in Patients With Multiple System Atrophy.1 passage
• Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.1 passage
• Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging.1 passage
• Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing.1 passage
• Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.1 passage
• Posterior cortical atrophy as an extreme phenotype of GRN mutations.1 passage
• Potential of the Antibody Against cis-Phosphorylated Tau in the Early Diagnosis, Treatment, and Prevention of Alzheimer Disease and Brain Injury.1 passage
• Precipitous Deterioration of Motor Function, Cognition, and Behavior.1 passage
• Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls.1 passage
• Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription.1 passage
• Prediction of Early Neurological Deterioration in Individuals With Minor Stroke and Large Vessel Occlusion Intended for Intravenous Thrombolysis Alone.1 passage
• Prediction of Early Recurrence After Acute Ischemic Stroke.1 passage
• Prehospital Comprehensive Stroke Center vs Primary Stroke Center Triage in Patients With Suspected Large Vessel Occlusion Stroke.1 passage
• Prehospital Stroke Management Optimized by Use of Clinical Scoring vs Mobile Stroke Unit for Triage of Patients With Stroke: A Randomized Clinical Trial.1 passage
• Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned.1 passage
• Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults.1 passage
• Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.1 passage
• Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome.1 passage
• Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework.1 passage
• Prevalence of Cardiovascular Risk Factors and Strokes in Younger Adults.1 passage
• Prevalence of Carriers of Intermediate and Pathological Polyglutamine Disease-Associated Alleles Among Large Population-Based Cohorts.1 passage
• Prevalence of High-risk Plaques and Risk of Stroke in Patients With Asymptomatic Carotid Stenosis: A Meta-analysis.1 passage
• Prevalence of Incidentally Detected Signs of Intracranial Hypertension on Magnetic Resonance Imaging and Their Association With Papilledema.1 passage
• Prevalence of Intracranial Aneurysm in Women With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular Dysplasia.1 passage
• Prevalence of Invalid Performance on Baseline Testing for Sport-Related Concussion by Age and Validity Indicator.1 passage
• Prevalence of Mathematical and Visuospatial Learning Disabilities in Patients With Posterior Cortical Atrophy.1 passage
• Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability.1 passage
• Prevalence of Systemic Atherosclerosis Burdens and Overlapping Stroke Etiologies and Their Associations With Long-term Vascular Prognosis in Stroke With Intracranial Atherosclerotic Disease.1 passage
• Preventing Cognitive Decline in Black Individuals With Mild Cognitive Impairment: A Randomized Clinical Trial.1 passage
• Preventing an Acute Flaccid Myelitis Epidemic in the Time of a Pandemic.1 passage
• Primary familial brain calcification with known gene mutations: a systematic review and challenges of phenotypic characterization.1 passage
• Procedural Clinical Complications, Case-Fatality Risks, and Risk Factors in Endovascular and Neurosurgical Treatment of Unruptured Intracranial Aneurysms: A Systematic Review and Meta-analysis.1 passage
• Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease.1 passage
• Prognosis of Asymptomatic Intracranial Stenosis in Patients With Transient Ischemic Attack and Minor Stroke.1 passage
• Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.1 passage
• Prognostic Value of Spreading Depolarizations in Patients With Severe Traumatic Brain Injury.1 passage
• Progress in Intravenous Thrombolytic Therapy for Acute Stroke.1 passage
• Progression in Behavioral Variant Frontotemporal Dementia: A Longitudinal Study.1 passage
• Progression in the LRRK2-Asssociated Parkinson Disease Population.1 passage
• Progressive Brain Atrophy in Super-refractory Status Epilepticus.1 passage
• Progressive Cortical Thinning in Patients With Focal Epilepsy.1 passage
• Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.1 passage
• Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy.1 passage
• Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke.1 passage
• Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.1 passage
• Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults.1 passage
• Quality of Care for Veterans With Transient Ischemic Attack and Minor Stroke.1 passage
• R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.1 passage
• Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease.1 passage
• Rapid Multifocal Neurologic Decline in an Immunocompromised Patient.1 passage
• Rapidly Progressive Quadriplegia and Encephalopathy.1 passage
• Rare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke: The NHLBI Exome Sequence Project.1 passage
• Rarity of the Alzheimer disease-protective APP A673T variant in the United States.1 passage
• Rate and Prognosis of Brain Ischemia in Patients With Lower-Risk Transient or Persistent Minor Neurologic Events.1 passage
• Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.1 passage
• Rates of Incidental Findings in Brain Magnetic Resonance Imaging in Children.1 passage
• Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.1 passage
• Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?1 passage
• Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment.1 passage
• Recommendations for the Management of Strokelike Episodes in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes.1 passage
• Recommendations for the Treatment of Patients With Parkinson Disease During Ramadan.1 passage
• Recovery After Mild Traumatic Brain Injury in Patients Presenting to US Level I Trauma Centers: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Study.1 passage
• Recovery of Consciousness and Functional Outcome in Moderate and Severe Traumatic Brain Injury.1 passage
• Recovery of cerebral blood flow following sports-related concussion.1 passage
• Recrudescence of Deficits After Stroke: Clinical and Imaging Phenotype, Triggers, and Risk Factors.1 passage
• Recruiting Patients With Stroke Into Cell Therapy Trials: A Review.1 passage
• Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.1 passage
• Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.1 passage
• Reperfusion Treatment and Stroke Outcomes in Hospitals With Telestroke Capacity.1 passage
• Research Criteria for the Behavioral Variant of Alzheimer Disease: A Systematic Review and Meta-analysis.1 passage
• Research Gaps and Controversies in Chronic Traumatic Encephalopathy: A Review.1 passage
• Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.1 passage
• Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor.1 passage
• Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis.1 passage
• Review of the Neurological Implications of von Hippel-Lindau Disease.1 passage
• Risk Factors Associated With Early vs Delayed Dementia After Intracerebral Hemorrhage.1 passage
• Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study.1 passage
• Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.1 passage
• Risk of Cerebral Venous Thrombosis in Obese Women.1 passage
• Risk of Depression and Anxiety in Adults With Cerebral Palsy.1 passage
• Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis.1 passage
• Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.1 passage
• Risk of Neuropathy Among 28,232 Patients With Biopsy-Verified Celiac Disease.1 passage
• Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis.1 passage
• Risk of Pregnancy-Associated Stroke Across Age Groups in New York State.1 passage
• Risk of Rupture After Intracranial Aneurysm Growth.1 passage
• Risk of Stroke at the Time of Carotid Occlusion.1 passage
• Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden: A Meta-analysis.1 passage
• Risk of Unnatural Mortality in People With Epilepsy.1 passage
• Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.1 passage
• Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial.1 passage
• Role of Population Receptive Field Size in Complex Visual Dysfunctions: A Posterior Cortical Atrophy Model.1 passage
• Role of endogenous neural stem cells in spinal cord injury and repair.1 passage
• Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.1 passage
• Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.1 passage
• Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized ClinicalTrial.1 passage
• Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.1 passage
• Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial.1 passage
• Safety and Efficacy of Fludrocortisone in the Treatment of Cerebral Salt Wasting in Patients With Tuberculous Meningitis: A Randomized Clinical Trial.1 passage
• Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial.1 passage
• Safety and Efficacy of Intra-arterial Urokinase After Failed, Unsuccessful, or Incomplete Mechanical Thrombectomy in Anterior Circulation Large-Vessel Occlusion Stroke.1 passage
• Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial.1 passage
• Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.1 passage
• Safety and Efficacy of a 3-Dimensional Stent Retriever With Aspiration-Based Thrombectomy vs Aspiration-Based Thrombectomy Alone in Acute Ischemic Stroke Intervention: A Randomized Clinical Trial.1 passage
• Safety and Outcome of Intra-Arterial Treatment for Basilar Artery Occlusion.1 passage
• Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.1 passage
• Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.1 passage
• Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures.1 passage
• Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.1 passage
• Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial.1 passage
• Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial.1 passage
• Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review.1 passage
• Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.1 passage
• Seizure Cycles in Focal Epilepsy.1 passage
• Seizure Prophylaxis After Spontaneous Intracerebral Hemorrhage.1 passage
• Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease.1 passage
• Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.1 passage
• Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.1 passage
• Sensitivity to the Deficits Associated With Traumatic Brain Injury or Chronic Traumatic Encephalopathy-Reply.1 passage
• Sensitivity to the Deficits Associated With Traumatic Brain Injury or Chronic Traumatic Encephalopathy.1 passage
• Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.1 passage
• Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.1 passage
• Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis.1 passage
• Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest.1 passage
• Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.1 passage
• Severe cognitive impairment associated with intrathecal antibodies to the NR1 subunit of the N-methyl-D-aspartate receptor in a patient with multiple sclerosis.1 passage
• Sex Differences in Academic Rank and Publication Rate at Top-Ranked US Neurology Programs.1 passage
• Sex Differences in Presentation and Outcome After an Acute Transient or Minor Neurologic Event.1 passage
• Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.1 passage
• Sex Disparities in Enrollment in Recent Randomized Clinical Trials of Acute Stroke: A Meta-analysis.1 passage
• Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease.1 passage
• Sex and Race Differences in the Association of Incident Ischemic Stroke With Risk Factors.1 passage
• Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.1 passage
• Sex-Specific Association of the X Chromosome With Cognitive Change and Tau Pathology in Aging and Alzheimer Disease.1 passage
• Sexual and Gender Minority Health in Neurology: A Scoping Review.1 passage
• Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.1 passage
• Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment.1 passage
• Skeletal Muscle Involvement in Antisynthetase Syndrome.1 passage
• Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease.1 passage
• Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.1 passage
• Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome.1 passage
• Spaceflight-Associated Brain White Matter Microstructural Changes and Intracranial Fluid Redistribution.1 passage
• Spatial and Temporal Pattern of Ischemia and Abnormal Vascular Function Following Traumatic Brain Injury.1 passage
• Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography.1 passage
• Standard vs Modified Antiplatelet Preparation for Preventing Thromboembolic Events in Patients With High On-Treatment Platelet Reactivity Undergoing Coil Embolization for an Unruptured Intracranial Aneurysm: A Randomized Clinical Trial.1 passage
• Stent Retrievers for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Clinical Trials.1 passage
• Subregional Pattern of Striatal Dopamine Transporter Loss on 18F FP-CIT Positron Emission Tomography in Patients With Pure Akinesia With Gait Freezing.1 passage
• Sudden Unexpected Death in Epilepsy Among Patients With Benign Childhood Epilepsy With Centrotemporal Spikes.1 passage
• Suicidality Risk of Newer Antiseizure Medications: A Meta-analysis.1 passage
• Surgical Decompression for Space-Occupying Hemispheric Infarction: A Systematic Review and Individual Patient Meta-analysis of Randomized Clinical Trials.1 passage
• Surgical Treatment of Nonlesional Neocortical Epilepsy: Long-term Longitudinal Study.1 passage
• Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis.1 passage
• Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.1 passage
• Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.1 passage
• Synthetic Nucleic Acids and Treatment of Neurological Diseases.1 passage
• Tackling Epilepsy With High-definition Precision Medicine: A Review.1 passage
• Tailoring the Approach to Embolic Stroke of Undetermined Source: A Review.1 passage
• Targeted drug delivery to flow-obstructed blood vessels using mechanically activated nanotherapeutics.1 passage
• Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.1 passage
• Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial.1 passage
• Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy.1 passage
• Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.1 passage
• Telemedicine in Prehospital Stroke Evaluation and Thrombolysis: Taking Stroke Treatment to the Doorstep.1 passage
• Temporal Dynamics of Cortical Microinfarcts in Cerebral Small Vessel Disease.1 passage
• The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.1 passage
• The Changing Landscape of Pediatric Migraine Therapy: A Review.1 passage
• The Emerging Role of Inhaled Heroin in the Opioid Epidemic: A Review.1 passage
• The Hazard of Negative (Not Neutral) Trials on Treatment of Acute Stroke: A Review.1 passage
• The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review.1 passage
• The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis.1 passage
• The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease.1 passage
• The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.1 passage
• Thirty Years After the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trial: A New Era for Stroke Therapy.1 passage
• Thrombectomy for Primary Distal Posterior Cerebral Artery Occlusion Stroke: The TOPMOST Study.1 passage
• Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial.1 passage
• Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury.1 passage
• Time Trends in the Incidence of Parkinson Disease.1 passage
• Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial.1 passage
• Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.1 passage
• Timed Light Therapy for Sleep and Daytime Sleepiness Associated With Parkinson Disease: A Randomized Clinical Trial.1 passage
• Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy.1 passage
• Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation.1 passage
• Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument.1 passage
• Transcranial Direct Current Stimulation vs Sham Stimulation to Treat Aphasia After Stroke: A Randomized Clinical Trial.1 passage
• Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis.1 passage
• Transient Focal Neurological Events in Cerebral Amyloid Angiopathy and the Long-term Risk of Intracerebral Hemorrhage and Death: A Systematic Review and Meta-analysis.1 passage
• Transient Neurological Symptoms in Patients With Intracerebral Hemorrhage.1 passage
• Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies.1 passage
• Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica: Influence of FCGR3A Polymorphisms on the Therapeutic Response to Rituximab.1 passage
• Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.1 passage
• Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective Study.1 passage
• Treatment of Cognitive Deficits in Genetic Disorders: A Systematic Review of Clinical Trials of Diet and Drug Treatments.1 passage
• Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.1 passage
• Trends Among Rural and Urban Medicare Beneficiaries in Care Delivery and Outcomes for Acute Stroke and Transient Ischemic Attacks, 2008-2017.1 passage
• Trends in Antihypertensive Medication Use Among Individuals With a History of Stroke and Hypertension, 2005 to 2016.1 passage
• Trends in Dementia Incidence in a Birth Cohort Analysis of the Einstein Aging Study.1 passage
• Trends in Optic Neuritis Incidence and Prevalence in the UK and Association With Systemic and Neurologic Disease.1 passage
• Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D.1 passage
• Trends in Relative Incidence and Prevalence of Dementia Across Non-Hispanic Black and White Individuals in the United States, 2000-2016.1 passage
• Trends in Reperfusion Therapy for In-Hospital Ischemic Stroke in the Endovascular Therapy Era.1 passage
• Trends in Status Epilepticus-Related Hospitalizations and Mortality: Redefined in US Practice Over Time.1 passage
• Trends in Stroke Incidence Rates in Older US Adults: An Update From the Atherosclerosis Risk in Communities (ARIC) Cohort Study.1 passage
• Twenty-Year Change in Severity and Outcome of Ischemic and Hemorrhagic Strokes.1 passage
• Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke.1 passage
• Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study.1 passage
• Unique Gadolinium Enhancement Pattern in Spinal Dural Arteriovenous Fistulas.1 passage
• Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.1 passage
• Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.1 passage
• Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.1 passage
• Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review.1 passage
• Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion.1 passage
• Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review.1 passage
• Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned.1 passage
• Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.1 passage
• Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity: The Mobile Parkinson Disease Score.1 passage
• Utility of Combining a Simulation-Based Method With a Lecture-Based Method for Fundoscopy Training in Neurology Residency.1 passage
• Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial.1 passage
• Validation of Altered Umbilical Cord Blood MicroRNA Expression in Neonatal Hypoxic-Ischemic Encephalopathy.1 passage
• Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation.1 passage
• Variability of Brain Death Policies in the United States.1 passage
• Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.1 passage
• Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort.1 passage
• Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults.1 passage
• When Do α-Synucleinopathies Start? An Epidemiological Timeline: A Review.1 passage
• Whole-Exome Sequencing in Familial Parkinson Disease.1 passage
• Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis.1 passage
• Worldwide barriers to organ donation.1 passage
• Zika Virus as an Emerging Global Pathogen: Neurological Complications of Zika Virus.1 passage
• Zolpidem for the Treatment of Neurologic Disorders: A Systematic Review.1 passage